ストックスクリーナーアプリを入手
73.98
3.35%
-2.44
前日終値:
$76.42
開ける：
$75.4
24時間の取引高:
1.92M
Relative Volume:
0.82
時価総額：
$11.49B
収益：
$4.39B
当期純損益:
$-1.58B
株価収益率:
-7.4277
EPS:
-9.96
ネットキャッシュフロー:
$546.00M
1週間 パフォーマンス:
-7.68%
1か月 パフォーマンス:
-12.99%
6か月 パフォーマンス:
-47.78%
1年 パフォーマンス:
-41.38%
1日の値動き範囲:
$70.64
$75.43
1週間の範囲:
$70.64
$82.76
52週間の値動き範囲:
$70.64
$156.66
Illumina Inc Stock (ILMN) Company Profile
ILMN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
73.90 | 11.49B | 4.39B | -1.58B | 546.00M | -9.96 |
|
TMO
Thermo Fisher Scientific Inc
|
444.29 | 171.01B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
186.09 | 134.77B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
396.31 | 32.47B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
104.98 | 29.63B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
157.59 | 28.04B | 15.41B | 1.37B | 2.11B | 7.50 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-04 | 繰り返されました | Citigroup | Neutral |
| 2025-02-28 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-02-10 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2025-02-07 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-11-12 | 再開されました | Morgan Stanley | Equal-Weight |
| 2024-10-17 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-08-28 | アップグレード | Argus | Hold → Buy |
| 2024-08-16 | アップグレード | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | アップグレード | Barclays | Underweight → Equal Weight |
| 2024-08-14 | アップグレード | TD Cowen | Hold → Buy |
| 2024-07-10 | アップグレード | Citigroup | Neutral → Buy |
| 2024-06-03 | 再開されました | Jefferies | Hold |
| 2024-01-16 | ダウングレード | HSBC Securities | Buy → Hold |
| 2024-01-04 | ダウングレード | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | アップグレード | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | アップグレード | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-14 | 開始されました | Stephens | Overweight |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-12-12 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-12-11 | アップグレード | Citigroup | Sell → Neutral |
| 2023-11-10 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | 開始されました | Bernstein | Underperform |
| 2023-07-05 | 再開されました | JP Morgan | Neutral |
| 2023-01-25 | ダウングレード | Argus | Buy → Hold |
| 2023-01-05 | 開始されました | Scotiabank | Sector Perform |
| 2022-12-12 | ダウングレード | Citigroup | Neutral → Sell |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-10-04 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | アップグレード | Evercore ISI | In-line → Outperform |
| 2022-08-25 | 開始されました | Credit Suisse | Neutral |
| 2022-07-13 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2022-01-18 | アップグレード | Stifel | Hold → Buy |
| 2022-01-11 | アップグレード | Barclays | Underweight → Equal Weight |
| 2022-01-07 | アップグレード | BofA Securities | Underperform → Neutral |
| 2022-01-06 | 再開されました | Morgan Stanley | Equal-Weight |
| 2022-01-06 | 再開されました | Piper Sandler | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-19 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | アップグレード | Evercore ISI | Underperform → In-line |
| 2021-03-31 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | 開始されました | Barclays | Underweight |
| 2020-12-22 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | アップグレード | BTIG Research | Neutral → Buy |
| 2020-10-13 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-09-30 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | ダウングレード | Stifel | Buy → Hold |
| 2020-09-22 | ダウングレード | UBS | Buy → Neutral |
| 2020-09-21 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-09-21 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-09-09 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-08-07 | ダウングレード | Evercore ISI | In-line → Underperform |
| 2020-08-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-04-24 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-04-21 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | 開始されました | Wells Fargo | Underweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2020-01-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-10-25 | 開始されました | Guggenheim | Buy |
すべてを表示
Illumina Inc (ILMN) 最新ニュース
Illumina stock hits 52-week low at $70.88 amid market challenges - Investing.com
Global Agrigenomics Market Is Booming So Rapidly 2025-2032 | BGI, Illumina, Inc., Eurofins Scientific SE - openPR.com
How Illumina employees step up, reach out, and give back - Illumina
Trexquant Investment LP Buys 20,506 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Characterizing alveolar dysregulation in pulmonary fibrosis using Illumina Spatial Technology - Illumina
Personalized Medicine Market Growth Trends 2025-2033: Transition to Customized Medical Care, Developments in Bioinformatics and Genomics, Growing Prevalence of Chronic Diseases - GlobeNewswire Inc.
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth TodayIllumina (NASDAQ:ILMN) - Benzinga
Argus cuts Illumina target, sees buying opportunity - Yahoo Finance
Illumina careers: Expanding access to NGS in emerging markets - Illumina
The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics - Nasdaq
Corvex’s Meister joins the board at Illumina. Here’s how he can create value for shareholders - MSN
Illumina, Inc. (NASDAQ:ILMN) Shares Sold by Artisan Partners Limited Partnership - MarketBeat
Illumina Adds Activist to Board, Names Former FDA Chief as Chair - MSN
Illumina stock hits 52-week low at $80.18 amid market challenges By Investing.com - Investing.com South Africa
Illumina stock hits 52-week low at $80.18 amid market challenges - Investing.com India
New in the lab: Test driving the MiSeq i100 Plus - Illumina
Analyst recommendations: Illumina, Boeing, Next, Walmart, Applovin.... - MarketScreener
AI In Genomics Market to Reach $9.8 Billion, Globally, by 2031 - openPR
NGS Sample Preparation Market Techniques Reshaping Genomic - openPR
Cathie Wood’s ARK trims Illumina, exits Repare Therapeutics stock By Investing.com - Investing.com South Africa
Cathie Wood’s ARK trims Illumina, exits Repare Therapeutics stock - Investing.com
May 9th Options Now Available For Illumina (ILMN) - Nasdaq
Is Illumina Undervalued After An 83% Drop In Its Stock Price? (NASDAQ:ILMN) - Seeking Alpha
Illumina is Now Oversold (ILMN) - Nasdaq
Canaccord maintains Illumina stock hold with $115 target By Investing.com - Investing.com UK
Activist investor Keith Meister to join Illumina's board - Reuters
Activist Investors Seize More Control of Illumina Amid Weakness - Markets Insider
Canaccord holds Illumina stock with $115 target amid board changes By Investing.com - Investing.com UK
Cintas, UPS, Illumina: Market Minute - Yahoo Finance
Illumina rises after board revamp - MSN
Illumina stock rises after board revamp (ILMN:NASDAQ) - Seeking Alpha
Activist Investor Meister to Join Illumina’s Board - WSJ
Activist investor Keith Meister to join Illumina’s board, WSJ reports - 1470 & 100.3 WMBD
Illumina Names Scott Gottlied as Non-Executive Board Chair; Corvex's Keith Meister Joins Board - MarketScreener
Illumina Board Of Directors Elects Dr. Scott Gottlieb Chair, Keith Meister To Join Board Of Directors - MarketScreener
Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors - PR Newswire
Activist investor Keith Meister to join Illumina's board, WSJ reports - MSN
Illumina shares rise on WSJ report activist investor Meister will join board By Investing.com - Investing.com UK
Activist investor Meister to join Illumina's board, WSJ reports - MarketScreener
Activist Investor Keith Meister Will Join The Board Of Directors Of Illumina- WSJ - MarketScreener
Single Cell Genome Sequencing Market Detailed In New Research - openPR
High End Cellomics Market Set to Witness Significant Growth - openPR
Scaling the genomics lab for the data deluge - Illumina
Illumina CIO Carissa Rollins to retire in April By Investing.com - Investing.com Australia
Illumina CIO Carissa Rollins to retire in April - Investing.com
Interrogating challenging genomic regions provides new answers for patients - Illumina
Unlocking a world of complete biological understanding - Illumina
Illumina Inc (ILMN) 財務データ
収益
当期純利益
現金流量
EPS
6.31%
1.59%
大文字化:
|
ボリューム (24 時間):